Sparrow Pharmaceuticals, Inc.
Edit

Sparrow Pharmaceuticals, Inc.

https://www.sparrowpharma.com/
Tags:ActiveCareChemicalDevelopmentDrugHealthTechLEDMedtechProduct
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.
Location: United States, Oregon, Portland
Member count: 1-10
Total raised: $50M
Founded date: 2013

Investors 4

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
18.05.2021Series A$50M-orbimed.co...

Mentions in press and media 7

DateTitleDescriptionCategoryAuthorSource
18.05.2021Sparrow Ph...---usvp.com/n...
18.05.2021Sparrow Ph...---orbimed.co...
18.05.2021Sparrow Ph...Sparrow Pharmaceuticals, an em...--marketscre...
13.04.2016It’s offic...A quartet of companies on Wedn...--medcitynew...
13.04.2016Day 2: INV...healthbox: the speed at which ...--medcitynew...
-Day 2: INV...Participate in the MedCity INV...--medcitynew...
-It’s offic...Today’s a day where you could ...--medcitynew...